{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:17:12Z","timestamp":1787242632015,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ncrna.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T21:21:07Z","timestamp":1687814467000},"page":"471-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Taha","family":"Aghajanzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-7234","authenticated-orcid":false,"given":"Mahmood","family":"Talkhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Baghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ncrna.2023.06.004_bib1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/imj.14709","article-title":"Non\u2010alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang","year":"2019","journal-title":"Intern. Med. J"},{"issue":"11","key":"10.1016\/j.ncrna.2023.06.004_bib2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ncrna.2023.06.004_bib3","series-title":"Non-alcoholic Fatty Liver Disease: A Practical Guide","author":"Farrell","year":"2013"},{"issue":"48","key":"10.1016\/j.ncrna.2023.06.004_bib4","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2007.12.024","article-title":"Getting to the root of miRNA-mediated gene silencing","volume":"132","author":"Eulalio","year":"2008","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ncrna.2023.06.004_bib6","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic micro RNA\u2010122 levels in patients with non\u2010alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.ncrna.2023.06.004_bib7","series-title":"Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers","first-page":"2020","author":"Khalifa","year":"2020"},{"key":"10.1016\/j.ncrna.2023.06.004_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ncrna.2023.06.004_bib9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/jcm4121953","article-title":"MicroRNAs in nonalcoholic fatty liver disease","volume":"4","author":"Baffy","year":"2015","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.ncrna.2023.06.004_bib10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ncrna.2023.06.004_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/1354750X.2018.1528631","article-title":"Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human","volume":"24","author":"Musaddaq","year":"2019","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib12","doi-asserted-by":"crossref","first-page":"Fso250","DOI":"10.4155\/fsoa-2017-0083","article-title":"Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression","volume":"4","author":"Nallagangula","year":"2018","journal-title":"Future Sci OA"},{"issue":"2","key":"10.1016\/j.ncrna.2023.06.004_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"48","key":"10.1016\/j.ncrna.2023.06.004_bib14","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","article-title":"Non invasive tools for the diagnosis of liver cirrhosis","volume":"20","author":"Soresi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"39","key":"10.1016\/j.ncrna.2023.06.004_bib15","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i39.11077","article-title":"Liver fibrosis in non-alcoholic fatty liver disease-diagnostic challenge with prognostic significance","volume":"21","author":"St\u00e5l","year":"2015","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"9","key":"10.1016\/j.ncrna.2023.06.004_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/cells8091003","article-title":"The miRFIB-Score: a serological miRNA-based scoring algorithm for the diagnosis of significant liver fibrosis","volume":"8","author":"Lambrecht","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ncrna.2023.06.004_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/cells9041005","article-title":"Noninvasive diagnosis of NAFLD and NASH","volume":"9","author":"Piazzolla","year":"2020","journal-title":"Cells"},{"issue":"D1","key":"10.1016\/j.ncrna.2023.06.004_bib18","first-page":"D148","article-title":"Updates to the experimentally validated microRNA\u2013target interaction database","volume":"48","author":"Huang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ncrna.2023.06.004_bib19","series-title":"Drug Target miRNA","first-page":"25","article-title":"Functional analysis of miRNAs using the DIANA tools online suite","author":"Vlachos","year":"2017"},{"key":"10.1016\/j.ncrna.2023.06.004_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.ncrna.2023.06.004_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: an online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PLoS One"},{"issue":"D1","key":"10.1016\/j.ncrna.2023.06.004_bib22","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ncrna.2023.06.004_bib23","first-page":"D101","article-title":"DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts","volume":"48","author":"Karagkouni","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ncrna.2023.06.004_bib24","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ncrna.2023.06.004_bib25","doi-asserted-by":"crossref","first-page":"D189","DOI":"10.1093\/nar\/gkz804","article-title":"RNAInter in 2020: RNA interactome repository with increased coverage and annotation","volume":"48","author":"Lin","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.ncrna.2023.06.004_bib26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.ncrna.2023.06.004_bib27","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Current protocols"},{"key":"10.1016\/j.ncrna.2023.06.004_bib28","series-title":"VENNY. An Interactive Tool for Comparing Lists with Venn Diagrams","author":"Oliveros","year":"2007"},{"issue":"W1","key":"10.1016\/j.ncrna.2023.06.004_bib29","doi-asserted-by":"crossref","first-page":"W171","DOI":"10.1093\/nar\/gky458","article-title":"eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks","volume":"46","author":"Clarke","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ncrna.2023.06.004_bib30","doi-asserted-by":"crossref","first-page":"D253","DOI":"10.1093\/nar\/gky1023","article-title":"TransmiR v2. 0: an updated transcription factor-microRNA regulation database","volume":"47","author":"Tong","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ncrna.2023.06.004_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bav095","article-title":"RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse","volume":"2015","author":"Liu","year":"2015","journal-title":"Database"},{"key":"10.1016\/j.ncrna.2023.06.004_bib32","first-page":"1","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","author":"Gy\u0151rffy","year":"2023","journal-title":"Geroscience"},{"issue":"7","key":"10.1016\/j.ncrna.2023.06.004_bib33","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"L\u00e1nczky","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"12","key":"10.1016\/j.ncrna.2023.06.004_bib34","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181006","article-title":"Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma","volume":"5","author":"Menyh\u00e1rt","year":"2018","journal-title":"R. Soc. Open Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib35","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","article-title":"Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets","volume":"8","author":"Nagy","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ncrna.2023.06.004_bib36","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ncrna.2023.06.004_bib37","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","article-title":"Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index","volume":"21","author":"Pang","year":"2015","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"5","key":"10.1016\/j.ncrna.2023.06.004_bib38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/jgh.12878","article-title":"MiR\u2010146b attenuates high\u2010fat diet\u2010induced non\u2010alcoholic steatohepatitis in mice","volume":"30","author":"Jiang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib39","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","article-title":"Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation","volume":"298","author":"Venugopal","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"31","key":"10.1016\/j.ncrna.2023.06.004_bib40","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.3748\/wjg.v25.i31.4468","article-title":"MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2","volume":"25","author":"Wu","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ncrna.2023.06.004_bib41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/0192623315573587","article-title":"Anti-fibrotic role of miR-214 in thioacetamide-induced liver cirrhosis in rats","volume":"43","author":"Izawa","year":"2015","journal-title":"Toxicol. Pathol."},{"issue":"7","key":"10.1016\/j.ncrna.2023.06.004_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0752-1","article-title":"MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression","volume":"9","author":"Ma","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ncrna.2023.06.004_bib43","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.3390\/ijms14048437","article-title":"Dual role of microRNAs in NAFLD","volume":"14","author":"Ceccarelli","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ncrna.2023.06.004_bib44","first-page":"112","article-title":"Effect of TGF-\u03b2\/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs)","volume":"10","author":"Davoodian","year":"2017","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"10.1016\/j.ncrna.2023.06.004_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1665-2681(19)30851-8","article-title":"Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats","volume":"13","author":"Ge","year":"2014","journal-title":"Ann. Hepatol."},{"issue":"9","key":"10.1016\/j.ncrna.2023.06.004_bib46","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1089\/dna.2019.5330","article-title":"HMGB1 inhibits HNF1A to modulate liver fibrogenesis via p65\/miR-146b signaling","volume":"39","author":"Ge","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"6","key":"10.1016\/j.ncrna.2023.06.004_bib47","first-page":"918","article-title":"MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4","volume":"15","author":"Ge","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ncrna.2023.06.004_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4168380","article-title":"Green tea prevents NAFLD by modulation of miR-34a and miR-194 expression in a high-fat diet mouse model","volume":"2019","author":"Torres","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13370-4","article-title":"Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ncrna.2023.06.004_bib50","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1111\/liv.14629","article-title":"LncRNA NEAT1: shedding light on mechanisms and opportunities in liver diseases","volume":"40","author":"Bu","year":"2020","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.ncrna.2023.06.004_bib51","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00109-017-1586-5","article-title":"NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6","volume":"95","author":"Yu","year":"2017","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-021-00632-8","article-title":"miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting \u03b2-catenin\/SOX9\/TGF-\u03b21 pathway","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discovery"},{"issue":"12","key":"10.1016\/j.ncrna.2023.06.004_bib53","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/iub.2140","article-title":"Long noncoding RNA XIST enhances ethanol\u2010induced hepatic stellate cells autophagy and activation via miR\u201029b\/HMGB1 axis","volume":"71","author":"Xie","year":"2019","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.ncrna.2023.06.004_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211016211","article-title":"LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1\/2 expression","volume":"49","author":"Liu","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ncrna.2023.06.004_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.etap.2016.05.014","article-title":"Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease","volume":"45","author":"Wang","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib56","first-page":"1","article-title":"lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3216-6","article-title":"Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression","volume":"17","author":"Chang","year":"2017","journal-title":"BMC Cancer"},{"issue":"5820","key":"10.1016\/j.ncrna.2023.06.004_bib58","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1126\/science.1137603","article-title":"Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR","volume":"315","author":"Passino","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ncrna.2023.06.004_bib59","doi-asserted-by":"crossref","first-page":"G631","DOI":"10.1152\/ajpgi.00185.2007","article-title":"Selective inactivation of NF-\u03baB in the liver using NF-\u03baB decoy suppresses CCl4-induced liver injury and fibrosis","volume":"293","author":"Son","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.06.004_bib60","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000485009","article-title":"Trolline ameliorates liver fibrosis by inhibiting the NF-\u03baB pathway, promoting HSC apoptosis and suppressing autophagy","volume":"44","author":"Bai","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"8\u20139","key":"10.1016\/j.ncrna.2023.06.004_bib61","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/jcb.29520","article-title":"MicroRNA\u2010326 attenuates hepatic stellate cell activation and liver fibrosis by inhibiting TLR4 signaling","volume":"121","author":"Liao","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.ncrna.2023.06.004_bib62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3349\/ymj.2020.61.8.660","article-title":"Overexpression of miR-146b-5p ameliorates neonatal hypoxic ischemic encephalopathy by inhibiting IRAK1\/TRAF6\/TAK1\/NF-\u03b1B signaling","volume":"61","author":"Yang","year":"2020","journal-title":"Yonsei Med. J."},{"issue":"4","key":"10.1016\/j.ncrna.2023.06.004_bib63","first-page":"3078","article-title":"MicroRNA-146a inhibits NF-\u03baB activation and pro-inflammatory cytokine production by regulating IRAK1 expression in THP-1 cells","volume":"18","author":"Zhou","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.ncrna.2023.06.004_bib64","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/ijms17071076","article-title":"MicroRNA-146a-5p negatively regulates pro-inflammatory cytokine secretion and cell activation in lipopolysaccharide stimulated human hepatic stellate cells through inhibition of toll-like receptor 4 signaling pathways","volume":"17","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2023.06.004_bib65","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","author":"Hern\u00e1ndez\u2013Gea","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ncrna.2023.06.004_bib66","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J. Hepatol."},{"issue":"48","key":"10.1016\/j.ncrna.2023.06.004_bib67","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-\u03baB signaling, liver disease and hepatoprotective agents","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ncrna.2023.06.004_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ncrna.2023.06.004_bib69","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2019.03.156","article-title":"A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice","volume":"513","author":"Choi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.ncrna.2023.06.004_bib71","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/ijms19061567","article-title":"Luteolin-mediated inhibition of hepatic stellate cell activation via suppression of the STAT3 pathway","volume":"19","author":"Cummins","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/cells9010030","article-title":"(\u2013)-Catechin-7-O-\u03b2-d-Apiofuranoside inhibits hepatic stellate cell activation by suppressing the STAT3 signaling pathway","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ncrna.2023.06.004_bib73","first-page":"1","article-title":"Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ncrna.2023.06.004_bib74","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/cells8101277","article-title":"Increased expression of RUNX1 in liver correlates with NASH activity score in patients with non-alcoholic steatohepatitis (NASH)","volume":"8","author":"Kaur","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ncrna.2023.06.004_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174137","article-title":"RUNX1 regulates SMAD1 by transcriptionally activating the expression of USP9X, regulating the activation of hepatic stellate cells and liver fibrosis","volume":"903","author":"Huang","year":"2021","journal-title":"Eur. J. Pharmacol."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054023000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054023000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:31:11Z","timestamp":1762835471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054023000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2468054023000380"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2023.06.004","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}